Get started
Author

Louise Cosand

Observed names: Cosand Louise, L Cosand, L. Cosand, L. D. Cosand, Louise D. Cosand
ORCID: 0009-0000-1896-0147
Observed ORCID: 0009-0000-1896-0147
OpenAlex ID: A5086544559
Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction
2003 · R M Shansky, C Glavis-Bloom, et al. · Molecular Psychiatry · 205
Altered resting state neuromotor connectivity in men with chronic prostatitis/chronic pelvic pain syndrome: A MAPP
2015 · Jason J. Kutch, Moheb S. Yani, et al. · NeuroImage Clinical · 84
PDF
Neurocognitive Workload Assessment Using the Virtual Reality Cognitive Performance Assessment Test
2009 · Thomas D. Parsons, Louise Cosand, et al. · Lecture notes in computer science · 31
PDF
Neurocognitive and Psychophysiological Analysis of Human Performance within Virtual Reality Environments
2009 · Parsons Thomas D., Iyer Arvind, et al. · Studies in health technology and informatics · 31
A Virtual Human Agent for Assessing Bias in Novice Therapists
2009 · Parsons Thomas D., Kenny Patrick, et al. · Studies in health technology and informatics · 18
Assessment of Psychophysiological Differences of West Point Cadets and Civilian Controls Immersed within a Virtual Environment
2009 · Thomas D. Parsons, Christopher Courtney, et al. · Lecture notes in computer science · 17
Real‐world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study
2025 · Louise Cosand, Haya Mayman, et al. · Developmental Medicine & Child Neurology · 16
Arousal, working memory, and conscious awareness in contingency learning
2008 · Louise D. Cosand, Thomas M. Cavanagh, et al. · Consciousness and Cognition · 12
Real-world use of trofinetide: a survey of practices from prescribers at Rett syndrome centers of excellence in the United States
2025 · Erin Prange, David Lieberman, et al. · Future Rare Diseases · 5
Considerations for Designing Response Quantification Procedures in Non-traditional Psychophysiological Applications
2009 · A. V. Iyer, L. D. Cosand, et al. · Lecture notes in computer science · 2
Characteristics of adult individuals with Rett syndrome treated or untreated with trofinetide in the United States
2026 · Nazia Rashid, Alyssa Peckham, et al. · Frontiers in Neurology · 1
PDF
Trofinetide treatment of Rett syndrome during routine health care: a plain language summary of the LOTUS study
2026 · Louise Cosand, Haya Mayman, et al. · Future Rare Diseases
PDF
Real-world Benefits and Tolerability of Trofinetide for the Treatment of Adults with Rett Syndrome: the LOTUS Study (P11-7.005)
2026 · Louise Cosand, Ryan Bucco · Neurology
P210: Real-world benefits and tolerability of trofinetide for the treatment of male patients with Rett syndrome: LOTUS study interim results
2026 · Arthur Beisang, Loan Robinson, et al. · Genetics in Medicine Open
PDF
P.082 Real-world benefits and tolerability of trofinetide for the treatment of pediatric and adult patients with Rett Syndrom: the LOTUS study
2025 · S Bond, H Mayman, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
PDF
P.081 Real-world benefits and tolerability of trofinetide for the treatment of Rett Syndrom: interim analysis of the LOTUS study
2025 · S Bond, H Mayman, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
PDF
P241: Real-world use of trofinetide: A survey of dosing strategies from US Rett syndrome centers of excellence
2025 · David Lieberman, Grace Correa, et al. · Genetics in Medicine Open
PDF
P210: Real-world trofinetide dosing for Rett syndrome: The LOTUS study
2025 · Louise Cosand, Victor Abler, et al. · Genetics in Medicine Open
CO68 Gastrointestinal Manifestations and Incontinence Products in the Real World Among Patients with Rett Syndrome in the United States
2023 · D. May, K. Kponee-Shovein, et al. · Value in Health
PDF
Awareness and conditioning: Who becomes aware (poster)
2006 · Thomas M. Cavanagh, Chistopher G. Courtney, et al.
Works count: 20
Citation count: 422
H-index: 8
I10-index: 8
Year
Topic
Type